Jiao J, Chen W
Front Public Health. 2024; 12:1385291.
PMID: 38887248
PMC: 11180828.
DOI: 10.3389/fpubh.2024.1385291.
Chan K, Song Y, Xu Z, Shang C, Zhou R
Biomolecules. 2022; 12(12).
PMID: 36551170
PMC: 9775976.
DOI: 10.3390/biom12121742.
Sawan H, Al Omari S, Al Bahar F, Karasneh R
PLoS One. 2022; 17(11):e0265797.
PMID: 36399447
PMC: 9674127.
DOI: 10.1371/journal.pone.0265797.
Helmy S, El-Morsi R, Helmy S, El-Masry S
J Drug Deliv Sci Technol. 2022; 76:103762.
PMID: 36097606
PMC: 9452404.
DOI: 10.1016/j.jddst.2022.103762.
Qureshi A, Syed Sulaiman S, Kumar N, Qureshi P
PLoS One. 2022; 17(7):e0270761.
PMID: 35793377
PMC: 9258860.
DOI: 10.1371/journal.pone.0270761.
Cocktail of REGN Antibodies Binds More Strongly to SARS-CoV-2 Than Its Components, but the Omicron Variant Reduces Its Neutralizing Ability.
Nguyen H, Lan P, Nissley D, OBrien E, Li M
J Phys Chem B. 2022; 126(15):2812-2823.
PMID: 35403431
PMC: 9016775.
DOI: 10.1021/acs.jpcb.2c00708.
COVID-19 pandemic: the delta variant, T-cell responses, and the efficacy of developing vaccines.
Biswas B, Chattopadhyay S, Hazra S, Hansda A, Goswami R
Inflamm Res. 2022; 71(4):377-396.
PMID: 35292834
PMC: 8923340.
DOI: 10.1007/s00011-022-01555-5.
A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations.
Chakraborty C, Sharma A, Bhattacharya M, Lee S
Front Immunol. 2022; 13:801522.
PMID: 35222380
PMC: 8863680.
DOI: 10.3389/fimmu.2022.801522.
Phage-Displayed Mimotopes of SARS-CoV-2 Spike Protein Targeted to Authentic and Alternative Cellular Receptors.
Petrenko V, Gillespie J, De Plano L, Shokhen M
Viruses. 2022; 14(2).
PMID: 35215976
PMC: 8879608.
DOI: 10.3390/v14020384.
Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe.
Thakur V, Bhola S, Thakur P, Patel S, Kulshrestha S, Ratho R
Infection. 2021; 50(2):309-325.
PMID: 34914036
PMC: 8675301.
DOI: 10.1007/s15010-021-01734-2.
Studies on Growth Characteristics and Cross-Neutralization of Wild-Type and Delta SARS-CoV-2 From Hisar (India).
Khandelwal N, Chander Y, Kumar R, Nagori H, Verma A, Mittal P
Front Cell Infect Microbiol. 2021; 11:771524.
PMID: 34888260
PMC: 8650692.
DOI: 10.3389/fcimb.2021.771524.
Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity.
Mengist H, Kombe Kombe A, Mekonnen D, Abebaw A, Getachew M, Jin T
Semin Immunol. 2021; 55:101533.
PMID: 34836774
PMC: 8604694.
DOI: 10.1016/j.smim.2021.101533.
The ongoing evolution of variants of concern and interest of SARS-CoV-2 in Brazil revealed by convergent indels in the amino (N)-terminal domain of the spike protein.
Resende P, Naveca F, Lins R, Dezordi F, Ferraz M, Moreira E
Virus Evol. 2021; 7(2):veab069.
PMID: 34532067
PMC: 8438916.
DOI: 10.1093/ve/veab069.